ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu

Noninvasive assessment of neuromuscular disease using electrical impedance (Skulpt Inc. EIM)

About the Study

Principal Investigator: Dr. Jeremy Shefner, State University of New York, Syracuse
Site-PI: Dr. Michael Benatar, University of Miami

eimThis is a multicenter study that is being done to further develop and refine a new handheld medical device called Electrical Impedance Myography (EIM) developed by Skulpt Inc. for the purpose of assessing amyotrophic lateral sclerosis. New methods for evaluating patients with ALS are needed to help assess the potential benefit of new therapies. The study will include the testing of muscles using a number of non-invasive techniques including EIM.

For ALS participants each study visit requires about 2-3 hours of time and there are 5 study visits over 9 months. Participants will be compensated up to $50 per visit.

For healthy controls and other neuromuscular disease participants the entire study will last no more than 3 hours. Only one visit is required. Participants will be compensated $20 for completing screening for the study and an additional $30 if eligible to participate and complete the visit

Eligibility Criteria

ALS Subjects:

  • Male or female, aged 35 to 80
  • Recent diagnosis of sporadic or familial ALS
  • Symptom onset less than 24 months before screening visit
  • Geographically accessible to the University of Miami Miller School of Medicine

Healthy Control subjects:

  • Male or female, aged 35 to 80
  • Absence of a known neurological disorder
  • Geographically accessible to the University of Miami Miller School of Medicine

Neuromuscular disorder subjects:

  • Male or female, aged 35 to 80.
  • Diagnosis of one of the following:
    • Multi-focal motor neuropathy
    • Autoimmune motor neuropathy
    • Pinched nerve in the neck or back causing weakness in the arms or legs
    • Weakness caused by neuropathy
    • Charcot-Marie-Tooth Disease
    • Cervical myelopathy
    • Multiple sclerosis
    • Hereditary spastic paraplegia
  • Geographically accessible to the University of Miami Miller School of Medicine
Funding Agencies

Skulpt Inc. via funding from

NIH_Master_Logo
National Institutes of Health

Collaborators
  • Massachusetts General Hospital
  • State University of New York Upstate Medical University
  • Wake Forest University Baptist Medical Center
  • Skulpt, Inc.
Contact

Research Coordinator

  • Sumaira Hussain, B.Sc.

Contact Information

  • Email: sumaira.hussain@med.miami.edu
  • Phone: 305-243-8487
Links
  • Skulpt Health
Publications
Presentations and Lectures
  • Bohorquez J, Jutkove S, Benatar M, Caress J, David W, Ensrud E, Shefner J. Electrical impedance myography for early diagnosis and assessment of ALS progression: Results of a multicenter clinical trial.  Platform presentation at the 27th International Symposium on ALS/MND, Dublin, Ireland, Dec 7-9, 2016.

Back to Research Studies

Active Research Studies

  • Research Studies (All)
  • Pre-fALS
  • CReATe PGB
  • PRESS-ALS
  • CRiALS Biomarker
  • CRiALS Genetics
  • Neuraltus NP001

Contact Us

By phone:
For familial ALS and general inquiries:
1-888-413-9315
For the CReATe Consortium and related studies:
1-844-837-1031

By email:
fals@miami.edu (For familial ALS inquiries)
projectcreate@miami.edu (For CReATe inquiries)
alsresearch@miami.edu (General inquiries)

Support Our Research

Affiliates

  • CReATe Consortium
  • CReATe Connect
  • The Kessenich Family ALS Center at UM
  • ALS Recovery Fund
  • ALS Association
  • Muscular Dystrophy Association
  • CDC National ALS Registry
  • The Northeastern ALS Consortium
  • Myasthenia Gravis Research Group
Read Our Newsletter

News

  • Biomarker for ALS Disease Progression Identified by the Teams at University of Miami and Flinders University!03/07/2017 - 5:48 pm
  • Brain MedicineDr. Benatar presents promising phase II trial results of Arimoclomol in SOD1 ALS12/09/2016 - 5:02 pm
  • CReATe Consortium Virtual Journal Club12/08/2016 - 3:18 pm
More News
© Copyright - ALS Research Collaboration. Site by Academic Web Pages
Scroll to top
Translate »